A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)-Reference-Cited by-同舟云学术

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

Published:2011-04-19 Issue:3 Volume:14 Page:226-233
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Hamaguchi Tetsuya, ,Shirao Kuniaki,Ohtsu Atsushi,Hyodo Ichinosuke,Arai Yasuaki,Takiuchi Hiroya,Fujii Hirofumi,Yoshida Motoki,Saito Hiroshi,Denda Tadamichi,Koizumi Wasaburo,Iwase Hiroaki,Boku Narikazu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10120-011-0030-8.pdf

Reference45 articles.

1. Statistics of Cancer, Center for Information Services, National Cancer Center, Japan. http://ganjoho.ncc.go.jp/public/statistics/pub/update.html .

2. Glimelius B, Hoffman K, Haglund U, Nyren O, Sjoden PO. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol. 1994;5:189–90.

3. Murad A, Santiago F, Petroianou A. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer. 1993;72:37–41.

4. Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer. 1995;71:587–91.

5. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215–21.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma;Clinical Cancer Research;2022-05-31

2. Histological evaluations of primary lesions are independently associated with prognosis in patients with gastric cancer who receive neoadjuvant chemotherapy;Oncology Letters;2017-04-18

3. Evaluations of primary lesions by endoscopy clearly distinguishes prognosis in patients with gastric cancer who receive chemotherapy;PLOS ONE;2017-03-13

4. Second-line chemotherapy for patients with advanced gastric cancer;Gastric Cancer;2017-03-04

5. Evolving treatments for advanced gastric cancer: appraisal of the survival trend;Expert Review of Anticancer Therapy;2016-05-23